APA (7th ed.) Citation

P, A., C, R., S, R., P, B., C, B., K, P., . . . A, A. (2021). The NHance® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients. Biomedicines, 9(6), . https://doi.org/10.3390/biomedicines9060665

Chicago Style (17th ed.) Citation

P, Aftimos, et al. "The NHance® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients." Biomedicines 9, no. 6 (2021). https://doi.org/10.3390/biomedicines9060665.

MLA (9th ed.) Citation

P, Aftimos, et al. "The NHance® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients." Biomedicines, vol. 9, no. 6, 2021, https://doi.org/10.3390/biomedicines9060665.